| David Luo, | |
|
1 Outlet Ln Ste 400, Suite 400, Lock Haven, PA 17745-7814 | |
| (570) 769-1300 | |
| Not Available |
| Full Name | David Luo |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 1 Outlet Ln Ste 400, Lock Haven, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164957379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS020642 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Residential Home Health Of Nc Pa, Llc | Williamsport, PA | Home health agency |
| Williamsport Regional Medical Center | Williamsport, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Susquehanna Physician Services | 2264336460 | 492 |
News Archive
More than 100 overweight young children from the New South Wales, Illawarra region are being sought to participate in one of the first randomised controlled trials of its kind in Australia that will help determine how best to tackle their obesity problem.
A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.
A University of California, San Diego (UCSD) School of Medicine collaborative study with Boston University's Slone Epidemiology Center found an increased risk of persistent pulmonary hypertension (PPHN) in newborns of mothers who used certain commonly prescribed antidepressants in late pregnancy.
BioMarin Pharmaceutical Inc. announced today that it has acquired ZyStor Therapeutics, Inc. (ZyStor), a privately-held biotechnology company developing enzyme replacement therapies (ERT) for the treatment of lysosomal storage disorders. ZyStor's lead product candidate is ZC-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for Pompe disease.
› Verified 2 days ago
| Entity Name | Susquehanna Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972548337 PECOS PAC ID: 2264336460 Enrollment ID: O20040426001371 |
News Archive
More than 100 overweight young children from the New South Wales, Illawarra region are being sought to participate in one of the first randomised controlled trials of its kind in Australia that will help determine how best to tackle their obesity problem.
A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.
A University of California, San Diego (UCSD) School of Medicine collaborative study with Boston University's Slone Epidemiology Center found an increased risk of persistent pulmonary hypertension (PPHN) in newborns of mothers who used certain commonly prescribed antidepressants in late pregnancy.
BioMarin Pharmaceutical Inc. announced today that it has acquired ZyStor Therapeutics, Inc. (ZyStor), a privately-held biotechnology company developing enzyme replacement therapies (ERT) for the treatment of lysosomal storage disorders. ZyStor's lead product candidate is ZC-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for Pompe disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Luo, 1201 Grampian Blvd, Suite 400, Williamsport, PA 17701-1900 Ph: () - | David Luo, 1 Outlet Ln Ste 400, Suite 400, Lock Haven, PA 17745-7814 Ph: (570) 769-1300 |
News Archive
More than 100 overweight young children from the New South Wales, Illawarra region are being sought to participate in one of the first randomised controlled trials of its kind in Australia that will help determine how best to tackle their obesity problem.
A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.
A University of California, San Diego (UCSD) School of Medicine collaborative study with Boston University's Slone Epidemiology Center found an increased risk of persistent pulmonary hypertension (PPHN) in newborns of mothers who used certain commonly prescribed antidepressants in late pregnancy.
BioMarin Pharmaceutical Inc. announced today that it has acquired ZyStor Therapeutics, Inc. (ZyStor), a privately-held biotechnology company developing enzyme replacement therapies (ERT) for the treatment of lysosomal storage disorders. ZyStor's lead product candidate is ZC-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for Pompe disease.
› Verified 2 days ago
Dr. Amit Mehta, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 955 Bellefonte Ave, Lock Haven, PA 17745 Phone: 570-748-7714 Fax: 570-893-6325 | |
Dr. Mary Elizabeth Piergallini, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 High St, Lock Haven, PA 17745 Phone: 570-747-7400 Fax: 570-748-8004 | |
Sarah Mcelroy, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 610 High St, Lock Haven, PA 17745 Phone: 570-748-1260 | |
Shannon Seeland, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 68 Spring St, Lock Haven, PA 17745 Phone: 800-230-4565 Fax: 570-893-6325 | |
Dr. Boris Gabinskiy, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 955 Bellefonte Ave, Lock Haven, PA 17745 Phone: 570-748-7714 Fax: 570-893-6325 | |
Dr. Laura May Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 610 High St, Lock Haven, PA 17745 Phone: 570-748-1260 Fax: 570-748-1261 |